## 



## 

## 

## 

## 

## 



## 



## 



## 



## 



## 



## 

## 

## 



## 

||||Unrestricted|Restricted|Total|Unrestricted|Restricted|Total|
|---|---|---|---|---|---|---|---|---|
||||Funds|Funds|2023|Funds|Funds|2022|
|||Note||6|8|6|||
|Income from:|||||||||
|Donations<br>and grants<br>Investments||2<br>3|65,544<br>9,636|23,664|89,208<br>9,636|66,591<br>6,537|1,091|67,682<br>6,537|
|Charitable<br>activities||4|49118||49 118|136214||136214|
|Total income|||124298|23664|147962|209342|1 091|210433|
|Expenditum<br>on:<br>Charitable<br>activities|||~168010|33516|201 526|265567|21 564|287 131|
|Total expenditure|||168010|33516|201 526|265567|21 564|287 131|
|Net gains/(losses)|on||30,903||30,903|(137,230)||(137,230)|
|investments|||||||||
|Net (expenditure)/income|||(12,809)|(9,852)|(22,661)|(193,455)|(20,473)|(213,928)|
|Transfers<br>Between Funds|||(1,411)|1,411|||||
|Net movement<br>in|funds||||||||
|Funds brought<br>forward at 1|||682,177|74,511|756,688|875,632|94,984|970,616|
|August 2022|||||||||
|Funds carried forward at 31|||||||||
|July 2023|||||||||





||||||2023|||2022||
|---|---|---|---|---|---|---|---|---|---|
|||||Note|8|||||
|Fixed assets||||||||||
|Investments||||||690,072|||649,740|
|Current assets||||||||||
|Cash at bank|and|in hand|||39,720|||100,103||
|Debtors||||7|26583|||12279||
||||||66,303|||112,382||
|Creditors||||||||||
|Amounts<br>falling due within|||one year|8|(22 348)|||(5434)||
|Net current assets||||||43|955||106948|
|Total assets|less|current|liabilities|10||734|27|||
|Represented|by:|||||||||
|Unrestricted|funds|||||687,957|||682,177|
|Restricted funds||||||66|070||74511|
||||||||||~7|






## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

|ONATION|S<br>AND GR|A|NTS||||||
|---|---|---|---|---|---|---|---|---|
|||||Unrestricted|Restricted|Total||Total|
|||||Funds|Funds|2023||2022|
|||||6|6|6|||
|Membership||||30,544||30,544||31,591|
|Capitation|Fee: Company||of Biologists|35,000||35,000||35,000|
|Travel Grant: Company||of|Biologists||23664|23664||1 091|
|||||||ILL2QB||QZJI82|
|NVESTME|NT INCOME||||||||
|||||Unrestricted|Restricted|Total||Total|
|||||Funds|Funds|2023||2022|
|||||6||6||6|
|UK quoted|investments|||9,429||9,429||6,530|
|Bank interest receivable||||207||207||7|
|NCOME FROM MEETINGS|||||||||
|||||Unrestricted|Restricted|Total||Total|
|||||Funds<br>6|Funds<br>6|2023f||2022<br>6|
|Spring meeting||||||~41|~1||



## 



## 

|XPENDITURE||||||
|---|---|---|---|---|---|
|||Unrestricted|Restricted|Total|Total|
|||Funds<br>8|Funds|2023<br>6|2022f|
|Grants to individuals||19,461|33,516|52,977|93,274|
|Spring meeting costs<br>Prizes||69,475<br>1,968||69,475<br>1,968|162,481<br>2,560|
|Autumn<br>meeting costs<br>Office costs and insurance||18,596<br>20,696||18,596<br>20,696|21,785|
|Wolpert<br>Memorial<br>Symposium||7,900||7,900||
|Film costs||25,282||25,282||
|Subscription s<br>Costs oftrustees'<br>meetings<br>Refunds ofoverpayments||775<br>313<br>50<br>164,516|33,516|775<br>313<br>50<br>198,032|2,280<br>1,621<br>705<br>284,706|
|Governance<br>—Independent|Examination|3494|~31|3494<br>2~01|2425<br>~71|



||No remuneration<br>has been paid to employees,<br>including<br>the members<br>ofthe Committe|No remuneration<br>has been paid to employees,<br>including<br>the members<br>ofthe Committe|No remuneration<br>has been paid to employees,<br>including<br>the members<br>ofthe Committe|No remuneration<br>has been paid to employees,<br>including<br>the members<br>ofthe Committe|No remuneration<br>has been paid to employees,<br>including<br>the members<br>ofthe Committe|e,<br>during the year.|e,<br>during the year.|
|---|---|---|---|---|---|---|---|
||During the year, travel expenses and other meeting costs of6313(2022:61,621)were|||||refunded to2 (2022:||
||10)members<br>ofthe Committee.|||||||
|6|FIXEDASSET INVESTMENTS|||||||
|||||||2023|2022|
|||||||6|6|
||Listed UK investments|||||||
||At 1 August 2022<br>Income reinvested||||649,740<br>9,429||780,440<br>6,530|
||Net unrealised|investment|gains/(losses)||~30 0||~137 230|
||Market value at|31 July 2023||||||
||Historic cost as|at 31 July|2023|||||
||The investments|are held|in the Baillie Gifford Managed|Fund and the|Legal &General|Unit Trust.||
|7|DEBTORS|||||||
|||||||2023|2022|
||||||||6|
||Prepayments<br>Other Debtors|||||24,530<br>2 053|12,279|
||Prepayments||||~2||~12 7|
|8|CREDITORS:|amounts|falling due within one year|||2023|2022|
||||||||6|
||Accruals|||||22 348<br>~4|5434<br>~44|





## 

## 

||||Balance at|||Fund|Balance at|
|---|---|---|---|---|---|---|---|
||||1 August|Income|Expenditure|Transfers|31July|
||||2022||||2023|
|Louie Hamilton|Fund||2,657||(200)||2,457|
|Travel Grants Fund|||28,328|23,664|(25,055)||26,937|
|Pl Travel Grant|||17,526||(5,850)||11,676|
|Practical Course Grant|||1,000||(2,411)|1,411||
|Dennis Summerbell<br>Total||Award|25000<br>~74<br>11|~24|~~t|1 411|25000<br>~7|
||||Balance at|||Fund|Balance at|
||||1 August|Income|Expenditure|Transfers|31 July|
||||2021||||2022|
||||||||9|
|Louie Hamilton|Fund||3,057||(400)||2,657|
|Travel Grants Fund|||39,567|1,091|(12,330)||28,328|
|Pl Travel Grant|||22,360||(4,834)||17,526|
|Practical Course Grant|||5,000||(4,000)||1,000|
|Dennis Summerbell||Award|25000||||25000|
|Total|||$444||(21~14||~74<br>11|





## 

## 

|ANALYSI|S OF NET ASSETS||||
|---|---|---|---|---|
||||Net current|Total|
|||Investments<br>f.|assets<br>f|2023|
|Unrestricted|funds|690,072|(22,115)|667,957|
|Restricted|funds||66,070|66070|
|||690072|43,955|734 027|
||||Net current|Total|
|||Investments<br>f|assets<br>f.|2022<br>f|
|Unrestricted|funds|649,740|32,437|682,177|
|Restricted|funds||74,511|74511|
|||649,740|106,948|756,688|



## 

